University of West Attica
Εμβολιασμός κατά της γρίπης σε ασθενείς με χρόνιες ηπατοπάθειες
Abstract
dc:descriptionIntroduction: Influenza vaccination is considered an effective strategy for preventing respiratory infections among patients with chronic liver disease.Aim: To assess influenza vaccination coverage among patients with chronic liver disease and identify the factors associated with vaccination uptake. Materials and Methods: A descriptive, cross-sectional, non-randomized study was conducted using a convenience sample of 300 patients with chronic liver disease. Data were collected at a tertiary hospital in Attica, Greece, between March 2022 and July 2023. A data collection form was used to record patients’ sociodemographic and clinical characteristics and their beliefs regarding influenza vaccination. Statistical significance was set at p≤0.05, and data were analyzed using SPSS version 26.0. Results: The participants’ mean age was 61.4 years (SD=12.1), and 56.3% were men. Overall, 54.7% had been vaccinated against influenza during the current influenza season, while 53.2% reported receiving the vaccine annually. Vaccination coverage was 44.8% for pneumococcal disease and 88.3% for SARS-CoV-2. Regarding liver disease, 55.0% had hepatitis B or C, 39.0% had liver cirrhosis, and 11.3% had hepatocellular carcinoma. Influenza vaccination coverage differed significantly according to age (p<0.001), employment status (p<0.001), and nationality (p=0.044). Significant differences were also observed according to the presence of hepatocellular carcinoma (p=0.044), hepatitis B (p=0.012), hepatitis C (p=0.025), diabetes mellitus (p=0.012), and heart disease (p=0.018). Participants vaccinated against influenza, pneumococcal disease, or SARS-CoV-2 expressed stronger agreement that vaccination is the most effective method of preventing influenza (p<0.001). Older participants were also more likely to consider vaccination the best preventive strategy (p<0.001) and to adhere to national vaccination recommendations. Conclusions: Although vaccination coverage in this sample was relatively high, substantial room for improvement remains. Increasing influenza vaccination uptake among patients with chronic liver disease requires a multifactorial approach.
Degree
thesis:*- Grantor dc:publisher
- University of West Attica
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dafnou, Paschalina
- Δάφνου, Πασχαλίνα
Subjects
dc:subject × 27- Hπατίτιδα Β
- Hπατίτιδα C
- Κίρρωση του ήπατος
- HKK - ηπατοκυτταρικό καρκίνωμα
- Λοίμωξη γρίπης
- Αντιγριπικός εμβολιασμός
- Πνευμονιόκοκκος
- SARS-CoV-2
- Εμβόλιο
- Πεποιθήσεις
- Εμβολιαστική συμμόρφωση
- Hepatitis B virus (HBV)
- Hepatitis C, Virus (HCV)
- Liver cirrhosis
- HCC hepatocellular carcinoma
- Influenza infection
- Influenza vaccination
- Pneumococcal disease
- Vaccine
- Beliefs
- Vaccination adherence
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Νοσηλευτική
- Health Sciences
- Medical and Health Sciences
- Nursing
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62930